Background: Renal cell carcinoma (RCC) with haemangioblastoma-like characteristics is a type of RCC reported in recent years. RCC with (angio) leiomyomatous stroma (RCCLMS) was included as a provisional entity of the 2016 World Health Organization (WHO) classification. RCC with haemangioblastoma-like characteristics and leiomyomatous stroma is extremely rare. This is the first report of a rare tumour harbouring TSC2 and SETD2 variations.

Case Presentation: The patient was a 38-year-old woman who presented with discomfort in the area of her right kidney. Ultrasound and enhanced CT showed a right renal mass, and clear cell renal cell carcinoma (CCRCC) was suspected; hence, robot-assisted laparoscopic nephron-sparing partial nephrectomy was performed. Gross examination revealed a well-circumscribed tumour measuring 2.0 cm × 1 cm × 0.7 cm under the renal capsule adjacent to the stripping edge that was greyish yellow and greyish red in colour. Histologic examination showed that the tumour consisted of three different structures: a CCRCC-like region, a haemangioblastoma-like region, and a focal leiomyomatous stroma component. Based on immunohistochemistry, the CCRCC-like region was diffusely strongly positive for AE1/AE3, vimentin, CAIX, PAX8, PAX2, CK7, and CAM5.2, partly positive for HNF1α, and negative for CD10, α-inhibin, NSE, S-100, CD34, and TFE3. The haemangioblastoma-like area was diffusely positive for vimentin, CAIX; partly positive for PAX8, PAX2, α-inhibin, and S-100; mostly positive for NSE; and slightly positive for HNF1α; the CD34 staining highlighted the complex capillary network. The Ki67 index was approximately 1-2% in the two above areas, and the leiomyomatous stroma was strongly positive for SMA. The whole-exon sequencing (WES) showed TSC2 and SETD2 variations. There was no progression after 18 months of follow-up.

Conclusion: We report for the first time a unique case of RCC with haemangioblastoma-like features and leiomyomatous stroma accompanied by rare molecular abnormalities. Whether this is a new tumour entity or a variant of clear cell carcinoma remains to be determined. The biological behaviour and clinical characteristics need to be further examined.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746168PMC
http://dx.doi.org/10.1186/s12957-022-02844-3DOI Listing

Publication Analysis

Top Keywords

leiomyomatous stroma
24
cell carcinoma
16
renal cell
12
tsc2 setd2
12
rcc haemangioblastoma-like
12
haemangioblastoma-like features
8
features leiomyomatous
8
unique case
8
setd2 variations
8
haemangioblastoma-like characteristics
8

Similar Publications

Introduction: Angiomyoadenomatous tumor as a nosological entity is not included in the latest version of the International Histological Classification of Kidney Tumors (WHO, 2022) and is related to provisional entity. Currently, there is no consensus among researchers about the nosological affiliation of an angiomyoadenomatous tumor.

Aim: To comparatively analyze the histological, immunophenotypic, ultrastructural and molecular parameters of renal angiomyoadenomatous tumor and clear cell papillary renal cell tumor.

View Article and Find Full Text PDF

Oral leiomyomatous hamartoma: presentation of 3 cases and review of the literature.

Oral Surg Oral Med Oral Pathol Oral Radiol

January 2024

Oral and Maxillofacial Pathology, Radiology and Medicine, New York University College of Dentistry, New York, NY, USA.

Oral leiomyomatous hamartoma (OLH) is a rare lesion, with only 40 cases reported in the literature. It typically presents early in life as a nodule on the anterior maxillary alveolar tissues or the tongue. Its growth potential is limited, with few cases reaching dimensions >2.

View Article and Find Full Text PDF

Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease characterized by hamartomatous tumors involving multiple organs such as the brain, skin, heart, lung and kidney. TSC is caused by inactivating mutations in TSC1/TSC2, which encodes hamartin and tuberin, respectively, and forms a complex that regulates mechanistic target of rapamycin complex 1 (mTORC1), resulting in cell overgrowth and oncogenesis. Since a leading cause of morbidity and mortality in TSC relates to chronic kidney disease and the ability to preserve renal function, this review describes the important pathologic findings in TSC-associated renal neoplasms and their correlating sporadic counterparts.

View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on rare renal cell carcinomas (RCCs) that show features similar to haemangioblastomas, with a specific look at their clinicopathological characteristics and VHL gene alterations, comparing them to clear cell renal cell carcinomas (CCRCCs) that also exhibit these features.
  • - The identified RCCs with haemangioblastoma-like features are generally indolent, have a distinct appearance with a thick capsule, and specific immunohistochemical profiles, but do not show typical VHL mutations, indicating a different molecular behavior.
  • - Findings suggest these RCCs can be differentiated from CCRCCs, as they exhibit unique features in terms of blood vessel and cell structure, as well as differences in genetic mutations
View Article and Find Full Text PDF
Article Synopsis
  • * Renal cell carcinomas with hemangioblastoma-like characteristics (RCC-HBs) were initially seen as a subtype of clear cell renal cell carcinoma (CCRCC) but are now understood to be distinct based on their immunohistochemical and molecular profiles.
  • * The study reviews and compares the features of RHB, RCC-HBs, and related tumors, aiming to clarify their similarities and differences to guide future research on their relationships with CNS-HB and other renal tumors.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!